Business and consumer attention is now focused on the latest technology trend – the Internet of Things (IoT).  The potential of IoT is huge, as no one wants to be left out of things, especially when so many new products and technologies are emerging on the market.    Analysts predict that the number of thingsaaa

“Imagine you wanted to study the taste of individual fruits. What would be the best approach? A blended fruit smoothie, or a fruit salad where you can taste the individual fruits one at a time? Ideally, you’d want the fruit salad.” This is the analogy that researchers at the Harvard Medical Institute use in aaaa

96% of venture capitalists are men1. Women still account for less than 10% of founders for high growth firms2 and earn only 12.9% of computer science degrees3. “She Started It” gives a new face to the image of the tech entrepreneur: a female face. Join Johnson & Johnson Innovation JLABS and the Innovation Forum foraaa

Date: 13 July 2017 Location: Wellcome Genome Campus Conference Centre, Hinxton Translational research is now at the forefront of most researchers minds. It has never been more crucial for R&D companies and for the benefit of society, to shorten the time to market for new drug and healthcare technologies. ON Helix, brought to you byaaa

2016 was a fantastic year for the global not-for-profit: the Innovation Forum. As a grassroots network of ~150 associates we managed to hold over 40 events across the globe, run an Accelerator that attracted close to 300 applicants and a global conference that peaked this year at over 600 attendees. In this post, I’ll runaaa

We invite you to submit research proposals to the SHIONOGI Science Program, an international collaboration call for drug discovery. The collaboration research budget will be a maximum of JPY 15 million per year per project for up to three years.   Shionogi has a strong track record in productivity in drug discovery. They generate moreaaa

The Innovation Forum is partnering with  Johnson & Johnson Innovation and the EBD group in organising the Start-up Slam in Barcelona, Spain. We believe this event offers a rare opportunity for start-up companies from across our global network: to gain international exposure in front of a specialist life-sciences audience, to raise funding from a diverse range of global investors and toaaa

Taking place on the 8-9th March 2017 in partnership with the Innovation Forum and NIHR, and developed by a cohort of thought leaders at J&J and Lilly this year’s congress marks the 10th anniversary of the world series. The Clinical Innovation and Partnering Congress will be showcasing disruptive tech, game-changing innovation, novel partnering strategies toaaa

NG:Safe will now receive a non-dilutive cash prize of $USD 30,000, additional mentorship and services through our network to rapidly accelerate their business.    NG:Safe is a Cambridge based medtech startup, developing a bedside diagnostic test that ensures correct placement of nasogastric feeding tubes (NGTs). NGTs are routinely used in the critical care setting but misplacementaaa